Protara Therapeutics, Inc. Common Stock (TARA)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Protara Therapeutics, Inc. Common Stock (TARA) is listed on Nasdaq, where it has traded since January 10, 2020.
- Listed On
- Nasdaq
- Listed Since
- January 10, 2020
- Employees
- 51
- Market Cap
- $156M
About Protara Therapeutics, Inc. Common Stock
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 116 institutions reported holding TARA, with 46.1 million shares worth $176.0 million in aggregate. The largest reported holder was Janus Henderson (Jupiter Topco), with 4.7 million shares worth $17.9 million. Of the 5 largest holders listed below, 4 added shares and 1 reduced its position during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Janus Henderson (Jupiter Topco) | 4,696,709 | $18M | Reduced 9.8% |
| BlackRock | 3,663,499 | $14M | Added 7.91% |
| Vanguard | 3,146,600 | $12M | Added 8.76% |
| Millennium Management | 3,101,166 | $12M | Added 9.54% |
| Velan Capital Investment Management | 2,844,652 | $11M | Added 0.35% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is TARA?
Protara Therapeutics, Inc. Common Stock (TARA) is listed on Nasdaq, where it has traded since January 10, 2020.
Who are the largest institutional holders of TARA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of TARA were Janus Henderson (Jupiter Topco), BlackRock and Vanguard.
How many institutions own TARA?
116 institutions reported a position in TARA for the quarter ended June 30, 2026, worth $176.0 million in total.
Did institutions buy or sell TARA last quarter?
Of the 5 largest reported holders, 4 added shares and 1 reduced its position during the quarter. Every reported holder and its change is on the SentiSense ownership page for TARA.
Every reported institutional holder, plus insider and congressional trades in TARA, on SentiSense.